DAIC

APRIL 12, 2024

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 1 To date, interventional treatment of coronary artery disease with drug-eluting stents has been able to establish flow angiographically. Food and Drug Administration (FDA).

Coronary Artery Disease 105

Coronary Artery Disease Technology Stent Stents 105

DAIC

MAY 14, 2024

The collaboration seeks to provide access to emerging technologies, like Medis QFR, while also reducing complexity in the cath lab to improve the operating environment for clinicians. Medis Medical Imaging has been developing innovative post-processing software for the quantification of cardiovascular images for thirty-five years.

Coronary Artery Disease 111

Coronary Artery Disease Interventional Cardiology Innovation Physiology 111

DAIC

APRIL 23, 2024

milla1cf Tue, 04/23/2024 - 15:53 April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes. February 18–21, 2024.

Aortic valve 111

Aortic valve Aortic Innovation Cardiothoracic 111

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. Surgical aortic valve replacement with a stented pericardial bioprosthesis: 5-year outcomes.

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109

DAIC

MARCH 20, 2024

1 To qualify for a Breakthrough Device Designation, a device technology must address an unmet need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly debilitating conditions. CLTI is associated with high rates of amputation and mortality as well as high care costs.1

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

MARCH 8, 2024

million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. A novel flexible stented blood inlet will conform to the shape of the patient’s heart to prevent flow stasis and clotting. Through a new four-year, $7.8 The research is funded by a four-year, $7.8

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

DAIC

FEBRUARY 24, 2025

By enabling the decisive shift from a reactive to a proactive cardiology model, this technology doesnt just improve patient outcomes it is also helping keep cardiovascular care sustainable and affordable. These costs represent a massive portion of total health expenditures. At the heart of AIs impact on cardiology?

Hospital 52

Hospital Cardiovascular Disease Heart Failure Heart Attack 52

ADN Center of Excellence

SEPTEMBER 27, 2023

Why IVUS and OCT Are Vital These technologies aren't just extras; they are the ticket to enhanced diagnostic accuracy and improved patient results. IVUS reveals plaque characteristics, optimal stent usage, and vessel measurements. Regular training acts as your compass in the ever-changing world of medical innovations.

Education 52

Education Best Practices Stent Stents 52

ADN Center of Excellence

OCTOBER 14, 2024

In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. Continuous Innovation in Medical Training The medical field is constantly evolving, and staying ahead requires continuous innovation in training methods.

Innovation 59

Innovation Technology Anatomy Stents 59

ADN Center of Excellence

OCTOBER 14, 2024

In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. Continuous Innovation in Medical Training The medical field is constantly evolving, and staying ahead requires continuous innovation in training methods.

Innovation 52

Innovation Technology Anatomy Stents 52

Dr. S. Venkatesan MD

FEBRUARY 29, 2024

Here comes the real Innovation. Fibro-Optic real shape( FORS) technology , which reconstructs image from optical data, and beam live fluro- like images, in 3 dimension. May be, we may soon, say good bye to electrons, protons, and welcome these harmless photons.

Ultrasound 52

Ultrasound Anatomy Stent Stents 52

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59